Author: Philip Lundgren

First Half-year 2025 Net profit amounted to MSEK 50.9 (-30.9). Earnings per share amounted to SEK 4.59 (-2.79). Net asset value amounted to MSEK 812 (SEK 73.32 per share) at June 30, 2025, compared to MSEK 808 (SEK 72.98 per share) at December 31, 2024. Net cash amounted to MSEK 220 (SEK 19.84 per share) […] Read more

Equip has sold all its shares in No Dig Alliance, the leading Nordic company in trenchless pipe renewal, to the European sustainability investor Ambienta   For more information: https://www.linkedin.com/posts/equip-capital_equip-exits-no-dig-alliance-equip-activity-7344286294740455425-Ew5q?utm_source=share&utm_medium=member_desktop&rcm=ACoAAABickEBsjLiMmyzHQn2IjA8k_qELd1IBMs Read more

NAXS has divested its 26,066 shares JDE Peet’s NV (Euronext Amsterdam: JDEP) for a total consideration of EUR 621,000.   The JDEP shares held by NAXS were received as an in-kind distribution from the JAB Consumer Fund II in October 2024.   For more information: https://www.jdepeets.com Read more

The board of directors of NAXS is pleased to announce its appointment of the board member Børge Johansen as interim CEO, effective June 13. This change follows notification from Nikolai Jebsen that he has accepted a new offer of employment which contractually requires him to resign his posts as interim CEO and as a board […] Read more

Almaviva, a leading Italian provider of digital solutions and technological transformation, has taken another bold step in its global trajectory by entering into a definitive agreement to acquire TIVIT, one of Brazil’s largest technology companies with a strong presence across Latin America, from funds advised by Apax Partners LLP.   For more information: https://www.apax.com/news-views/almaviva-signs-agreement-to-acquire-tivit-from-the-apax-funds-to-accelerate-its-digital-expansion-in-latin-america/ Read more

Minerva Imaging (“Minerva”) is a market-leading, science-driven Contract Research Organisation (“CRO”) and Contract Development and Manufacturing Organisation (“CDMO”), specialising in the development of targeted radioligand therapies — a fast-emerging and transformative field within cancer therapeutics. The partnership will support Minerva’s growth journey and ambition to build a global market-leading radiopharmaceutical platform   With deep expertise […] Read more

For more information: https://emmabodaglas.se/ Read more

For more information: https://storage.googleapis.com/corporate-sites-ldc-x85-prod/Apax_Funds_acting_through_Nordahl_Bid_Co_AB_complete_t_9b605c1016/Apax_Funds_acting_through_Nordahl_Bid_Co_AB_complete_t_9b605c1016.pdf Read more

First quarter 2025 Net profit amounted to MSEK 94.4 (1.1). Earnings per share amounted to SEK 8.52 (0.10). Net asset value amounted to MSEK 903 (SEK 81.50 per share) at March 31, 2025, compared to MSEK 808 (SEK 72.98 per share) at December 31, 2024. Net cash amounted to MSEK 198 (SEK 17.90 per share) […] Read more

On 3 April 2025 the annual general meeting of NAXS AB (publ) resolved in accordance with the following Adoption of the annual accounts, distribution of profit, etc. The annual general meeting adopted the income statements and balance sheets for the parent company and the group for the year 2024 and resolved that SEK 4.25 per […] Read more